Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.68 |
| ▸ | MEN1 | O00255 | 4/20 | 0.68 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.68 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.68 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.68 |
| ▸ | IGF1R | P08069 | 3/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.57 |
| ▸ | PKM | P14618 | 1/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31341343 | 0.95 | GAA (0.90) | GAAKMT2AMEN1KDM4EOPRM1 | |
| SCHEMBL10746494 | 0.91 | GAA (0.82) | GAAKMT2AMEN1KDM4EOPRM1 | |
| SCHEMBL2796836 | 0.91 | GAA (0.82) | GAAKMT2AMEN1KDM4EOPRM1 | |
| SCHEMBL24672691 | 0.86 | GAA (0.75) | GAAKMT2AMEN1KDM4EOPRM1 | |
| Acetic Acid SCHEMBL9325415 | 0.86 | GAA (0.75) | GAAKMT2AMEN1KDM4EOPRM1 | |
| SCHEMBL3976521 | 0.85 | GAA (0.74) | GAAKMT2AMEN1KDM4EOPRM1 | |
| SCHEMBL1461910 | 0.85 | GAA (0.73) | GAAKMT2AMEN1KDM4EOPRM1 | |
| SCHEMBL7428354 | 0.84 | GAA (0.73) | GAA | |
| Hydrochloric Acid SCHEMBL10502374 | 0.84 | GAA (0.73) | GAAKMT2AMEN1KDM4EOPRM1 | |
| SCHEMBL1205842 | 0.83 | GAA (0.71) | GAAKMT2AMEN1KDM4EOPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250179233-A1 | PROCESS AND CATALYSTS FOR HYDROGEN MEDIATED ANIONIC COPOLYMERIZATION OF CONJUGATED DIENES AND LIQUID COPOLYMERS THEREOF | ALBEMARLE CORPORATION (US) | 2025-06-05 | — | — | US | claimed |
| EP-4486808-A2 | PROCESS AND CATALYSTS FOR HYDROGEN MEDIATED ANIONIC COPOLYMERIZATION OF CONJUGATED DIENES AND LIQUID COPOLYMERS THEREOF | ALBEMARLE CORPORATION (US) | 2025-01-08 | — | — | EP | claimed |
| CN-119137172-A | Process and catalyst for hydrogen-mediated anionic copolymerization of conjugated dienes and liquid copolymers thereof | 雅宝公司 | 2024-12-13 | — | — | CN | claimed |
| WO-2023168218-A2 | PROCESS AND CATALYSTS FOR HYDROGEN MEDIATED ANIONIC COPOLYMERIZATION OF CONJUGATED DIENES AND LIQUID COPOLYMERS THEREOF | ALBEMARLE CORPORATION (US) | 2023-09-07 | — | — | WO | claimed |
| US-20250179233-A1 | PROCESS AND CATALYSTS FOR HYDROGEN MEDIATED ANIONIC COPOLYMERIZATION OF CONJUGATED DIENES AND LIQUID COPOLYMERS THEREOF | ALBEMARLE CORPORATION (US) | 2025-06-05 | — | — | US | disclosed |
| EP-4486808-A2 | PROCESS AND CATALYSTS FOR HYDROGEN MEDIATED ANIONIC COPOLYMERIZATION OF CONJUGATED DIENES AND LIQUID COPOLYMERS THEREOF | ALBEMARLE CORPORATION (US) | 2025-01-08 | — | — | EP | disclosed |
| CN-119137172-A | Process and catalyst for hydrogen-mediated anionic copolymerization of conjugated dienes and liquid copolymers thereof | 雅宝公司 | 2024-12-13 | — | — | CN | disclosed |
| WO-2023168218-A2 | PROCESS AND CATALYSTS FOR HYDROGEN MEDIATED ANIONIC COPOLYMERIZATION OF CONJUGATED DIENES AND LIQUID COPOLYMERS THEREOF | ALBEMARLE CORPORATION (US) | 2023-09-07 | — | — | WO | disclosed |
| EP-3322706-B1 | SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS | ARRAY BIOPHARMA INC (US) | 2020-11-11 | — | — | EP | disclosed |
| WO-2018136661-A1 | SUBSTITUTED PYRAZOLO[1,5-a]PYRAZINE COMPOUNDS AS RET KINASE INHIBITORS | ANDREWS STEVEN W (US) | 2018-07-26 | — | — | WO | disclosed |
| US-20180186796-A1 | COMPOUNDS AND USES THEREOF | LEAD DISCOVERY SIENA S.R.L. (IT) | 2018-07-05 | — | — | US | disclosed |
| US-20180186796-A1 | COMPOUNDS AND USES THEREOF | LEAD DISCOVERY SIENA S.R.L. (IT) | 2018-07-05 | — | — | US | disclosed |
| US-20150152045-A1 | REACTIVE IONIC LIQUIDS | BASF SE | 2015-06-04 | — | — | US | disclosed |
| US-20120016124-A1 | SEROTONIN REUPTAKE INHIBITORS | BAYLOR UNIVERSITY (US) | 2012-01-19 | — | — | US | disclosed |
| US-7893261-B2 | bi-functional organic molecules which combine serotonin transporter reuptake inhibition with serotonin (5-HT, such as 5-HT2A) receptor antagonism in one molecular entity | BAYLOR UNIVERSITY (US) | 2011-02-22 | — | — | US | disclosed |
| US-20080214572-A1 | Selected Tetracyclic Tetrahydrofuran Derivatives Containing a Cyclic Amine Side Chain | FERNANDEZ-GADEA FRANCISCO JAVIER | 2008-09-04 | — | — | US | disclosed |
| US-20080214572-A1 | Selected Tetracyclic Tetrahydrofuran Derivatives Containing a Cyclic Amine Side Chain | FERNANDEZ-GADEA FRANCISCO JAVIER | 2008-09-04 | — | — | US | disclosed |
| US-20080132514-A1 | Serotonin Reuptake Inhibitors | BAYLOR UNIVERSITY | 2008-06-05 | — | — | US | disclosed |
| EP-1732610-A2 | TARGETED SEROTONIN REUPTAKE INHIBITORS | BAYLOR UNIVERSITY (US) | 2006-12-20 | — | — | EP | disclosed |
| WO-2005094896-A2 | TARGETED SEROTONIN REUPTAKE INHIBITORS | BAYLOR UNIVERSITY (US) | 2005-10-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120016124-A1 | SEROTONIN REUPTAKE INHIBITORS | HTR2A, HTR2C, HTR1A | GAA 3584/4885KMT2A 839/4885MEN1 4852/4885 |
| US-20180186796-A1 | COMPOUNDS AND USES THEREOF | FYN, SRC, HCK | GAA 2132/4885KMT2A 2777/4885MEN1 3464/4885 |
| US-20150152045-A1 | REACTIVE IONIC LIQUIDS | INPPL1, PIK3CG, PTEN | GAA 3797/4885KMT2A 1774/4885MEN1 1765/4885 |
| US-20080132514-A1 | Serotonin Reuptake Inhibitors | HTR2A, HTR2C, HTR1A | GAA 3584/4885KMT2A 839/4885MEN1 4852/4885 |
| US-20080214572-A1 | Selected Tetracyclic Tetrahydrofuran Derivatives Containing a Cyclic Amine Side Chain | HTR2C, HTR2A, HTR5A | GAA 3308/4885KMT2A 1784/4885MEN1 4384/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.